Is pheochromocytoma confirmed by measuring fractionated metanephrines in a 24‑hour urine collection or plasma free metanephrine test?

Pheochromocytoma Diagnosis: Metanephrine Testing

Yes, pheochromocytoma is confirmed biochemically by measuring either plasma free metanephrines or 24-hour urinary fractionated metanephrines, with both tests showing excellent diagnostic accuracy (sensitivity 92-97%, specificity 89-96%). However, these tests confirm biochemical excess, not the tumor itself—anatomical imaging and histopathology provide definitive confirmation 1.

Primary Recommendation

The Endocrine Society Clinical Practice Guideline (2014) recommends initial biochemical testing should include measurements of plasma free metanephrines OR urinary fractionated metanephrines 1. Both are considered first-line tests with comparable diagnostic performance.

Key Performance Metrics

Plasma free metanephrines:

• Sensitivity: 92-97% 1, 2
• Specificity: 93-96% 1, 2
• Highest accuracy when obtained supine after 30-minute rest 2

24-hour urinary fractionated metanephrines:

• Sensitivity: 90-95% 1, 3, 2
• Specificity: 86-93% 1, 3, 2
• Slightly lower specificity than plasma testing 2

Critical Nuances in Test Selection

When Plasma Testing is Superior

Plasma free metanephrines measured by LC-MS/MS under optimal conditions (supine, 30-minute rest) provide the highest diagnostic accuracy 2. This is particularly important for:

• **Small tumors (<2 cm)**: Recent evidence shows small pheochromocytomas can present with normal or borderline 24-hour urine metanephrines while plasma metanephrines are significantly elevated (>2-fold) 4
• Early detection in hereditary surveillance: Plasma normetanephrine may detect early-stage noradrenergic tumors before urinary metabolites become abnormal 5
• Lipid-poor adrenal incidentalomas: When urine tests are normal but clinical suspicion remains high, plasma testing can confirm diagnosis 4

Sampling Conditions Matter

Supine plasma sampling after 30-minute rest significantly outperforms seated sampling:

• Supine: 95% sensitivity, 95% specificity
• Seated: 89% sensitivity, 93% specificity 2

The supine position maintains constant 95% accuracy across all disease prevalence rates, while seated sampling accuracy decreases from 94% to 89% as prevalence increases 2.

Common Pitfalls and How to Avoid Them

False Negatives

Small tumors are the most common cause of false-negative results 6. The 2026 Japanese multicenter study found current cutoff values showed only 82.2% sensitivity overall and 76.0% for abdominal paragangliomas, with false-negative cases having significantly smaller tumors than true-positives 6.

Solution: When clinical suspicion is high despite normal urine metanephrines:

• Order plasma free metanephrines with LC-MS/MS under optimal conditions (supine, 30-minute rest) 4
• Consider functional imaging (MIBG, PET) 6
• Use lower cutoff thresholds: optimized values (plasma metanephrine >120 pg/mL or normetanephrine >290 pg/mL) improved sensitivity to 92.5% while maintaining 99.2% specificity 6

Test Interpretation

Express results as fold-elevation above upper reference limit 7. A sum of ratios (normetanephrine + metanephrine) with:

• Cutoff ≥1: High sensitivity screening (95-96%)
• Cutoff ≥2: High specificity confirmation (improves specificity for ruling in disease) 7

Plasma metanephrines show larger fold-increases than urinary metabolites (9.5-fold vs 7.1-fold for normetanephrine in pediatric patients), potentially making interpretation more straightforward 5.

Interchangeability of Tests

Plasma and urine metanephrines are statistically correlated and can be used interchangeably for initial screening 3. The 2024 study demonstrated significant correlation between plasma and urinary metanephrine levels, and between plasma and urinary normetanephrine levels 3.

However, they are not redundant—when one test is equivocal or borderline, the other can provide confirmatory or complementary information 4, 6.

Practical Algorithm

1. Initial screening: Order either plasma free metanephrines (supine, 30-min rest) OR 24-hour urinary fractionated metanephrines 1

2. If positive (≥2-fold elevation): Proceed to anatomical imaging 1

3. If borderline (1-2 fold elevation):

   • Order the alternative test (if urine was done, get plasma; if plasma was done, get urine) 4, 6
   • Ensure optimal sampling conditions for plasma testing 2

4. If negative but high clinical suspicion (especially with small lipid-poor adrenal masses):

   • Order plasma free metanephrines by LC-MS/MS under optimal conditions 4
   • Consider functional imaging 6

5. Confirmation: Histopathology after surgical resection with postoperative biochemical testing to confirm normalization 4, 6